Showing results (81-90 of 104) with videos related to
Sort By:
Pageof 11
Nature Communications|September 6, 2022
Structural basis for recognition of N-formyl peptides as pathogen-associated molecular patternsGeng Chen, Xiankun Wang, Qiwen Liao, et al.Optics Express|May 5, 2017
Terahertz generation mechanism in nano-grating electrode photomixers on Fe-doped InGaAsPReshma A Mohandas, Joshua R Freeman, Michele Natrella, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 12, 2010
Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantationLindsay L Rosenbeck, Patrick J Kiel, Iftekhar Kalsekar, et al.Bone Marrow Transplantation|July 6, 2020
Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndromeVaibhav Agrawal, Praveen Ranganath, Kirsten D Ervin, et al.Nature|January 25, 2019
Structural insights into the activation of metabotropic glutamate receptorsAntoine Koehl, Hongli Hu, Dan Feng, et al.Nature|July 1, 2021
G-protein activation by a metabotropic glutamate receptorAlpay B Seven, Ximena Barros-Álvarez, Marine de Lapeyrière, et al.Nature|March 1, 2019
Author Correction: Structural insights into the activation of metabotropic glutamate receptorsAntoine Koehl, Hongli Hu, Dan Feng, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2006
Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphomaRichard I Fisher, Steven H Bernstein, Brad S Kahl, et al.Nature Immunology|May 1, 2010
The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammationHua-Chen Chang, Sarita Sehra, Ritobrata Goswami, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancerMichael J Robertson, James W Mier, Theodore Logan, et al.Pageof 11